ToxSci Advance Access originally published online on May 27, 2004
Toxicological Sciences 2004 81(1):139-147; doi:10.1093/toxsci/kfh179
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Toxicological Sciences vol. 80 no. 1 © Society of Toxicology 2004; all rights reserved.
Endocrine Disruptors (Environmental Estrogens) Enhance Autoantibody Production by B1 Cells

* Department of Molecular Preventive Medicine, School of Medicine, The University of Tokyo, Tokyo, 113-0033, Japan; and
Department of Public Health, Toyama Medical and Pharmaceutical University, 930-0194, Japan
Received March 19, 2004; accepted May 18, 2004
Accumulating data suggest that endocrine disruptors affect not only the reproductive system, but also the immune system. We demonstrate here that endocrine disruptors including diethylstilbestrol (DES) and bisphenol-A (BPA) enhance autoantibody production by B1 cells both in vitro and in vivo. BWF1 mice, a murine model for systemic lupus erythematosus (SLE), implanted with Silastic tubes containing DES after orchidectomy developed murine lupus characterized by immunoglobulin G (IgG) anti-DNA antibody production and IgG deposition in the glomeruli in the kidney as well as those implanted with 17ß-estradiol (E2). Plaque-forming cells (PFC) producing autoantibodies specific for bromelain-treated red blood cells were significantly increased in mice implanted with DES and BPA. IgM antibody production by B1 cells in vitro was also enhanced in the presence of endocrine disruptors including DES and BPA. Estrogen receptor (ER) expression was upregulated in B1 cells in aged BWF1 mice that developed lupus nephritis. These results suggest that endocrine disruptors are involved in autoantibody production by B1 cells and may be an etiologic factor in the development of autoimmune diseases.
Key Words: endocrine disruptors; environmental estrogens; autoantibody; B cell; systemic lupus erythematosus; SLE.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. S. Brown Jr. Effects of Bisphenol-A and Other Endocrine Disruptors Compared With Abnormalities of Schizophrenia: An Endocrine-Disruption Theory of Schizophrenia Schizophr Bull, January 1, 2009; 35(1): 256 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Petri Sex hormones and systemic lupus erythematosus Lupus, May 1, 2008; 17(5): 412 - 415. [Abstract] [PDF] |
||||
![]() |
S. H. Windahl, M. K. Lagerquist, N. Andersson, C. Jochems, A. Kallkopf, C. Hakansson, J. Inzunza, J.-A. Gustafsson, P. T. van der Saag, H. Carlsten, et al. Identification of Target Cells for the Genomic Effects of Estrogens in Bone Endocrinology, December 1, 2007; 148(12): 5688 - 5695. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Salazar, M. R. Miller, J. B. Barnett, and R. Schafer Evidence for a Novel Endocrine Disruptor: The Pesticide Propanil Requires the Ovaries and Steroid Synthesis to Enhance Humoral Immunity Toxicol. Sci., September 1, 2006; 93(1): 62 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-j. Yan, E. Albesiano, N. Zanesi, S. Yancopoulos, A. Sawyer, E. Romano, A. Petlickovski, D. G. Efremov, C. M. Croce, and N. Chiorazzi B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia PNAS, August 1, 2006; 103(31): 11713 - 11718. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Jacobi and B. Diamond Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus J. Exp. Med., August 1, 2005; 202(3): 341 - 344. [Abstract] [Full Text] [PDF] |
||||





